Vincent Aurentz
2016
In 2016, Vincent Aurentz earned a total compensation of $1.1M as Executive Vice President and Chief Business Officer at Arena Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $67,025 |
|---|---|
| Option Awards | $835,920 |
| Salary | $151,538 |
| Other | $55,678 |
| Total | $1,110,161 |
Aurentz received $835.9K in option awards, accounting for 75% of the total pay in 2016.
Aurentz also received $67K in non-equity incentive plan, $151.5K in salary and $55.7K in other compensation.
Rankings
In 2016, Vincent Aurentz's compensation ranked 7,732nd out of 14,075 executives tracked by ExecPay. In other words, Aurentz earned more than 45.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,732 out of 14,075 | 45th |
Division Manufacturing | 2,931 out of 5,489 | 47th |
Major group Chemicals And Allied Products | 964 out of 1,895 | 49th |
Industry group Drugs | 748 out of 1,538 | 51st |
Industry Pharmaceutical Preparations | 594 out of 1,176 | 50th |
Source: SEC filing on April 28, 2017.
Aurentz's colleagues
We found six more compensation records of executives who worked with Vincent Aurentz at Arena Pharmaceuticals in 2016.
2016
Amit Munshi
Arena Pharmaceuticals
Chief Executive Officer
2016
Dominic Behan
Arena Pharmaceuticals
Chief Scientific Officer
2016
Steven Spector
Arena Pharmaceuticals
General Counsel
2016
Kevin Lind
Arena Pharmaceuticals
Chief Financial Officer
2016
Craig Audet
Arena Pharmaceuticals
Former Senior Vice President, Operations and Head of Global Regulatory Affairs
2016
Harry Hixson
Arena Pharmaceuticals